3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Lung Neoplasms
6
Neoplasms
4
Colonic Neoplasms
3
Prostatic Neoplasms
2
Patient Satisfaction
2
Ovarian Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Tuberculosis, Pulmonary
1
Thoracic Diseases
1
Supratentorial Neoplasms
1
Stomach Ulcer
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Polyps
1
Pituitary Neoplasms
1
Pain, Postoperative
1
Pain
1
Overweight
1
Obesity
1
Neurofibromatoses
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Interventions
Metformin
9
Liraglutide
3
Exercise
3
semaglutide
2
Tirzepatide
2
Nutrition Assessment
2
Docosahexaenoic Acids
2
Diet
2
sibutramine
1
Ursodeoxycholic Acid
1
Topiramate
1
Solutions
1
Resistance Training
1
Propofol
1
Progestins
1
Nutrition Therapy
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Magnetic Resonance Spectroscopy
1
Injections
1
Hysteroscopy
1
Exenatide
1
Estrogen Replacement Therapy
1
Doxorubicin
1
Cyproterone
1
Cyclophosphamide
1
Caloric Restriction
1
(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Obesity
×
Propofol
×
Clear all
NCT05518929
2024-06-07
SpO2
RenJi Hospital
Phase 4
Completed
1,090 enrolled